Pfizer Inc.

Registered Principal Details

Business Or Interest:
Pharmaceutical manufacturing and healthcare.

Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries

CEO Name:
Albert Bourla

Contact
TB
Thomas Brownlie
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
jskelton@politicomlaw.com
http://www.pfizer.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 173
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
4/14/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 203
Senate Bill 203
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
4/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health Services: Departmentwide
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide

Notification Date
2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Health Services: Medicaid Services
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services

Notification Date
2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Insurance: Departmentwide
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide

Notification Date
2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Insurance: Supervision of the Insurance Industry
Biennial budget bill treatment of matter relating to
Insurance: Supervision of the Insurance Industry

Notification Date
2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

Regulation of pharmaceutical sales representatives
Development, drafting or introduction of a proposal relating to
Regulation of pharmaceutical sales representatives

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/28/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Regulation of pharmacy benefit managers
Development, drafting or introduction of a proposal relating to
Regulation of pharmacy benefit managers

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/28/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Federal 340B drug discount program
Development, drafting or introduction of a proposal relating to
Federal 340B drug discount program

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/28/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Establishment of a Prescription Drug Affordability Review Board
Development, drafting or introduction of a proposal relating to
Establishment of a Prescription Drug Affordability Review Board

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/28/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Prescription Drug Importation
Development, drafting or introduction of a proposal relating to
Prescription Drug Importation

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/28/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Regulation of pharmaceutical manufacturers
Development, drafting or introduction of a proposal relating to
Regulation of pharmaceutical manufacturers

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/28/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Rare Disease Day
Development, drafting or introduction of a proposal relating to
Rare Disease Day

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/28/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Application of Prescription Drug Payments for Health Coverage
Development, drafting or introduction of a proposal relating to
Application of Prescription Drug Payments for Health Coverage

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/28/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

No certified reports found.

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

No legislative bills/resolutions found.

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

No topics found.

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures